University of California San Francisco
Give to UCSF
Three UCSF research fellows are exploring the role food insecurity plays in poor health related to infectious diseases, as part of the University of California Global Food Initiative.
We asked experts across UCSF to identify what's ahead in how we approach research, what disease areas will see major advances, and where basic science will be translating into real treatments.
HIV can lurk for a lifetime in the body, so to truly cure patients, scientists are trying to find ways to target these HIV reservoirs in a strategy known as “shock and kill.”
In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.
In a new look at the groundbreaking iPrEx trial for people at high risk of HIV infection, UCSF researchers have identified strong evidence of efficacy for transgender women when PrEP is used consistently.
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UCSF.
In a project spearheaded by investigators at UCSF, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Research is a key component of UCSF's work at San Francisco General Hospital, and a new proposed research facility will support breakthroughs there for decades to come.
A team led by researchers from UCSF, Organic Health Response and Microclinic International is reporting results of a study that showed significant benefits of microclinics – an innovative intervention that mobilized rural Kenyan HIV patients’ informal social networks to support their staying in care.
Recognizing that patients’ experiences of childhood and adult trauma are common and have a direct impact on their health, UCSF clinical researchers and Positive Women’s Network-USA have developed and are reporting a new primary care model.
New clinical research from UCSF shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants.
Zian H. Tseng, MD, MAS, associate professor of medicine in residence in the Cardiology Division and Cardiac Electrophysiology Service at UC San Francisco, received a four-year $2.14 million grant from the National Institutes of Health (NIH) to expand on his research of people with HIV/AIDS and their increased risk of sudden cardiac death.
The UCSF Clinician Consultation Center at San Francisco General Hospital and Trauma Center has been funded to provide a PrEPline, a telephone consultation service that gives expert guidance to healthcare providers across the nation who prescribe antiretroviral medications to prevent HIV.
New research from UC San Francisco found that 60 percent of the city’s homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
New research from UC San Francisco shows that an “expressive therapy” group intervention conducted by The Medea Project helps women living with HIV disclose their health status and improves their social support, self-efficacy and the safety and quality of their relationships.